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of interest over the he 
tted using a thee co 
Noninvasive r proaches to define the effect of coronary 
artery disease on regional t~y~~~ia~ blood Row using 
accurate quantitative flow measurements in human patients 
may enhance our understanding of disease processes and 
improve subsequent treatment strategies. Sophisticated 
techniques available in the animal model (1) allow the 
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quantitative assessment of regional myocardia! blood 
flow under a variety of experi eatal conditions. Most of 
these techniques are invasive (flow probes) or ire the 
postmortem analysis of tissue ~dioactivity (r abeled 
mierosphcres). Therefore, transfer of these technologies to 
the human heart is limited. Several imaging approaches 
have recently been introduced (2-S) to qualitatively evalu- 
ate myocardial blood flow: these include radionuclide 
methods, echocardio~ra~hy, nuclear magnetic resonance 
imaging and dynamic X-ray compu tomo~rapby. Thal- 
lium-201 scintigraphy represents t most widely used 
noni~vas~ve approach to assess myocardial blood flow (2,5). 
It provides high diagnostic accuracy for the identification 
of coronary artery disease, but can detect only relative 
blood flow abnormalities. In addition, the low photon 
energy of thallium-201 results in significant photon attenua- 
tion by tissue surrounding the heart, which degrades the 
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owcve~, evert t 
i~~~tia~ tracer extracti 
sion to ~)utar~iue can 
based on initial myocardial N-13 
of measurable myocardi 
an volunteers free of 
cardiovascular disease as assessed by history and physical 
examination partici this i~vest~~atio~. The mean ag 
was 24 rt 4 years. ‘ects were studied under fastin 
conditions (>I2 b). After giving informed, written consent, 
each subject was positioned in the ECAT-911 (CTI) whole 
body scanner for image acquisition. 
ar scan was 
te attenualion cor- 
rection factors. Ten miil~c~ries of N-13 a~~rnoflia was in- 
~~trave~ous~y as a slow bolus over 30 s using, a 
Harvard infusion pump (Could, Inc.). Simultaneously, dy- 
namic image acquisition was initiated with varying frame 
durations. Twelve 10 s frames were followed by four 30 s 
myocardial tissue. 
3) The extracel~~~ar and ~~trace~~~~ar PJ- I3 am ia pools 
rapidly equilibrate. 
4) The available ~lutamine synthrtasc Ieve) refocus es- 
sentially ancban~ed t rc, 
ro~a~~~ity that an a SC 
to ~lutami~e remains constant. 
Componenrs qfrhe mo vesl this set of ass~m~ti 
simple linear first order di equations can be der 
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Table 1. Symbols Used in the Model Equations 
Symbol 
c, W 
c, (1) 
cr (1) 
Co (0 
1*,,, (I) 
c, (1) 
4 
kz 
kll 
A 
Description 
Arterial blood N-13 
ammonia concentration 
Total tissue N-13 
concentration 
N-13 ammonia 
concentration in tissue 
N-13 glutamine 
concentration in tissue 
Measured N.13 
concentration 
Measured tioque N.-l3 
concenrration 
Ammonid uptake n\te 
Ammonia waskouI rate 
we constant 
N*13 decay conatanl 
Units 
mCi/ml blood 
mCi/g tissue 
mCi/g tissue 
mCi/g tissue 
mCi/ml 
mCi/ml 
mill ’ 
min ’ 
p tissue 
tl 
I2 
TBV 
F 
E 
Ps 
Tissue density 
Start scan time 
End scan time 
Fractional blood volume 
Fractional blood volume 
spillover 
Total fractional blood 
volume 
Blood flow 
Extraction fraction 
Permeability-surface area 
product 
g hue/ml tissue 
min 
min 
ml blood/ml 
ml blood/ml 
ml blood/ml 
ml/g per min 
Unilless 
~minlml 
, represents the combined processes of 
ry of the ~dion~cl~de to the tissue by bl 
at-action of the tracer across the capiil 
ce m a single capillary transit and must have units of 
tissue per min. The other constants of the model 
Al are true rate constants (min-‘1. reflecting the 
that a single radionucli 
rtment will either be lo 
to another com~a~me~t. Solution of equations 1 and 2 (see 
Appendix) yields a description of the concentration of N-13 
in myocardial tissue as a function of time (C&l). 
- e”q @C,(t). 1.31 
1 
ented by the data, and 
tissue as a resuh 0 
same physical measurement volume. It is important to note 
that the tissue (C&l) and blood components (C,[t]) of the 
measurement (C&l) must be scaled by the fraction of the 
of the 
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nia ratio clearly demonstrates the increased uptake of the 
tracer at ow ntas. 
An PX ofr@ml titnc-wtivity crtrves generated by 
placing a region of interest over the wall of the ieft vcntriclc 
and left ventricular chamber for a rest and dipyridamole 
study are shown in Figure 3. The concentration of N-13 
ammonia levels increases rapidly as the bolus of activit 
the blood transverses the tissue (approximately 2 min). 
myocardial N-13 ammonia level reaches G plateau af?e 
mains constant throughout the rcmaindcr 
c uptake and retention uf N-13 ~mrno~i~ 
after dipyridamole infusion. The conccn- 
tration of N-13 ammonia measured over the fim~l 360 s of 
tudy normalized by the i he N-i3 ammonia 
~~n~~nt~ti~n ave 
seline level when dipyri 
timeaCtivity curves obtained C-0 
OVW the Ie ricular chamber (ci 
s Cwqwes). 
infusfan in the same patient, 
re 2, Serial cross-sectional posi- 
emission t~rno~r~~~~~c images 
ventricle obtained at 
afier di~y~darn~~e in- 
Py, N-13 ammonia con- 
ght and iefr vea~~cu~~~r 
ch~rn~rs~ The later 
r~t~ll~ioa of N- 13 am 
car&urn. 
rcsidua 
the tail of the fit. However, the additional term in the model 
did not eliminate se&l 
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estimates for each segment of the left ventricle 
he results show a mean coronary tlaw reserve of 
shows that the eonanwry RQW IWCMC was 
ughout the left ventricular myocardium. 
The data presented in 
y of estimating regional 
uman heart with N-13 ammonia and 
ission tomographic imaging. By using a 
ree compartment tracer kinetic model, 
isolation of the initial extraction of ttacer by the tissue from 
s quent metabolic radionuclide trapping in the form of 
amine can bc achic 
h r~~r~s~nts the d 
ammonia. can be used as an 
flow as long as the single pass 
is, the perrneabi~~l~su~acc area 
b flow). The magnitude of 
V observed in this study 
model. The l~~asur~d cora 
normal volunteers agrees closely with results obtained by a 
variety of other ind~~~de~t tecbai 
digital angiography, thermodiiution or 
perfusion, but do not provide 
out assessing the tissue mass 
coronary artery. Ther~forc, th 
sion tomographic measurements in the human heart by 
independent methods based on velocity measurements in 
epicardial arteries may be limited and was not attempted in 
this study. 
Wt r. The “ideal” blood flow 
tracer is expected to be highly extracted by the myocardium 
and its tissue retention to be linearly related to flow over a 
wide range. Radiolabeled microspheres fulfill these criteria, 
extraction by the tissue, which is indepen- 
dent af the flow state (8.28). However. the need for arterial 
it$ection of this tracer limits its clinical use. O-15 water is 
highly extracted by tissue and can be used as an intrave- 
nously injected flow tracer (7,9,10,29). However, this tracer 
is freely diffusible across membranes, which results in rapid 
clearance kinetics from myocardium and only little contrast 
between blood and tissue activity. Application of O-15 water 
for the evaluation of myocardial blood flow by positron 
emission tomography requires delineation of blood activity 
rate extraction from reten- 
pass extraction of N-13 ammonia has not been determined in 
Calculations of the ext~ct~o~ fraction over the flow range 
observed in our study predict a decrease in the extraction 
fraction to only 92% ~measured ow IF] 460 ml/min per 100 
g). Thus, blood flow will be only slightly underestimated WI 
the basis of K, measurements of the kinetic model. This 
assumption is confir d by the magnitude of coronary 
reserve calculated in e studied volunteers. The a 
value of 4.8 closely agre 
The results of the 
curve fit residuals shown in Figure 4 demonstrate the validity 
of this model to describe the N-13 ammonia kinetics. With 
practicability of the 
ach without the need 
emission tomographic studies evaluating t 
from the tissue after a bolus 
at which radioactivity egres 
tional to the geometry of the tissue 
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partial volume distortions (32). However. examination of the 
error properties for dynamic O-15 water techniques in the 
brain, as demonstrated by Koeppe et al. (331, shows that the 
coefficient Jf variation for model washout variables is much 
larger than the coefficient of variation of K,, the model 
variable describing the uptake of tracer. Therefore, studies 
designed to examine the relative change in myocardial blood 
flow when comparing physiologic states are more effective 
estimates of the uptake variable rather than the wash- 
out model variables, Conversely, the development of studies 
c absolute estimate of myocardinl blood 
ppropriately suited for a technique that is 
free of partial volume distortions, In the present study. this 
technique was developed for the estimation of coronary 
reserve, which reflects relutivc changes uf flow and is, 
therefore, lesti sensitive to partial volume effects. 
The data presented here were ohtaincd in healthy volun- 
teers. Further studies are required to assess the error sensi- 
tivity of the proposed approach in patients with coronary 
artery disease. Blood Bow reduction may be more difficult to 
accurately assess. Low count statistics and geometric Fac- 
tors (wall thinning) may limit the application of this approach 
under such circumstances (32,341. 
Conclusions. Dynamic positron emission tomographic 
imaging with N-13 ammonia allowed the quantitative LZSSESS- 
ment of myocardial blood Row at rest and after intruveneus 
infusion of dipyridamolc; the data agreed well with those 
obtained by independent techniques such as digital angiog- 
raphy and Doppler catheter estimates. With use of a now 
tracer kinetic model, N-13 ammonia extraction can be scp- 
anted from the metabolic N-13 ammonia tissue retention. 
Blood flow measurements based on N-13 ammonia cxtrac- 
flow sttttes and less sensitive 
ttblic environment. 
~rn~n~t~t~~ the feasibility of noni~v~siv~ 
nal coronary reserve by using 
phy, which will allow assessment 
of regional coronary artery 
disease and evaluation of vascular conductance in various 
cardix diseasas. Further clinical studies in patients with 
copQnetry artery disease will determine the diagnostic value 
ve flow measurements for assessing the severity 
artery disease. Thus. positron emission tomop 
to objectively define the 
vide absolute flow crite- 
the effect of coronary 
model describing the behavior of N-13 ammonia in 
ssue 
I) 
is based on the following assumptions: 
capil 
N-13 ammonia behaves iike a freely diffusible tracer at the 
-myocardiid tissue interface. 
2) N-13 ammonia is converted to N-13 glutamine by glutamine 
synthetase and is “essentially” trapped within the myocardiat 
tissue. 
3) The extracellular and intracellular N-13 ammonia pools rap- 
idly equilibrate. 
4) The available glutamine synthetase level remains essentially 
unchanged throughout the study and, therefore the ~~ohahi~ity that 
an ammonia molecule in the tissue is converted to ghnamine remains 
constant. 
These simple assumptions lead to a set of linear first order 
differential equations dsscrihing the kinetics observed in rnyo~~rd~nl 
tissue (see Table I for abbreviations): 
dC# 
--f 
dt 
,C,,(U -. k:CI_(l) - k&:(l) - AC,:(l) 
A solution 10 this SC1 of COWpICJ d~l~e~effil~~~l qMilti~~~~S can L-r0 d&ml 
using Laplacc transform te~l~niqu~s f35L The first step in tbc 
derivation consists of taking the Laplncc tr~~osSorm of c 
and 2a: 
Substitution of equation $1 into equation 6a yields: 
Equations 5a and la can now bc inverse ~~~~~l~e-t~~nsfo~rnc~ to 
form an expression for the radionuclide concentration in each tissue 
com~~ment us a function of time. uation 5a is easily separates 
into the product of two functions C,,(s) and K,Ns + kz + k, + A). 
Therefore. the expression for f&O will be the convolution of the 
inverse transform of each of these functions: 
Therefwc: 
Becnuse the urter~~l input curve C,,(tl wilt vary From patient to 
patient or study to study, it cannot be 
the use of an equation. 
escribed explicitly through 
Inverse transformation of equation 7a is a little more complex 
because it does not cast itself into a form that is easily transformed. 
However. if the two terms in the denominator of this 
multiplied. a quadradic function of s is 
expression are 
pro 
4k, + kj + 2A) + A(k? + k, t A,. Illal 
P
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